Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Ruzzi

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Cancer Research|December 14, 2021
Integrated Molecular Characterization of Patient-Derived Models Reveals Therapeutic Strategies for Treating CIC-DUX4 SarcomaMarianna Carrabotta, Maria Antonella Laginestra, Giorgio Durante, et al.
Biomedicines|October 27, 2022
Prevention and Therapy of Metastatic HER-2<sup>+</sup> Mammary Carcinoma with a Human Candidate HER-2 Virus-like Particle VaccineFrancesca Ruzzi, Arianna Palladini, Stine Clemmensen, et al.
JCO Precision Oncology|December 5, 2024
Clinical and Preclinical Activity of EGFR Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Harboring <i>BRAF</i> Class 3 MutationsAlessandro Di Federico, Stefania Angelicola, Mariateresa Frascino, et al.
Scientific Reports|August 23, 2019
Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigationsPatrizia Nanni, Lorena Landuzzi, Maria Cristina Manara, et al.
JCO Precision Oncology|January 29, 2026
Erratum: Clinical and Preclinical Activity of EGFR Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Harboring BRAF Class 3 MutationsAlessandro Di Federico, Stefania Angelicola, Mariateresa Frascino, et al.
Psychiatry Research|February 3, 2023
Socio-demographic and clinical characteristics of SARS-CoV-2-positive psychiatric in-patients: A case-control study in the psychiatric wards of a Great Metropolitan Hospital in MilanMauro Percudani, Adelaide Panariello, Giacomo Deste, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 7, 2025
Genomic profiling of a collection of patient-derived xenografts and cell lines identified ixabepilone as an active drug against chemo-resistant osteosarcomaMaria Cristina Manara, Francesca Bruzzese, Laura Formentini, et al.
Scientific Reports|January 16, 2021
Early stability and late random tumor progression of a HER2-positive primary breast cancer patient-derived xenograftLorena Landuzzi, Arianna Palladini, Claudio Ceccarelli, et al.
Harvard Review of Psychiatry|May 12, 2021
Universal and Selective Interventions to Prevent Poor Mental Health Outcomes in Young People: Systematic Review and Meta-analysisGonzalo Salazar de Pablo, Andrea De Micheli, Marco Solmi, et al.
Journal of Translational Medicine|January 3, 2025
PD-L1 and IFN-γ modulate Non-Small Cell Lung Cancer (NSCLC) cell plasticity associated to immune checkpoint inhibitor (ICI)-mediated hyperprogressive disease (HPD)Stefania Angelicola, Francesca Giunchi, Francesca Ruzzi, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Cancer Research|December 14, 2021
Integrated Molecular Characterization of Patient-Derived Models Reveals Therapeutic Strategies for Treating CIC-DUX4 SarcomaMarianna Carrabotta, Maria Antonella Laginestra, Giorgio Durante, et al.
Biomedicines|October 27, 2022
Prevention and Therapy of Metastatic HER-2<sup>+</sup> Mammary Carcinoma with a Human Candidate HER-2 Virus-like Particle VaccineFrancesca Ruzzi, Arianna Palladini, Stine Clemmensen, et al.
JCO Precision Oncology|December 5, 2024
Clinical and Preclinical Activity of EGFR Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Harboring <i>BRAF</i> Class 3 MutationsAlessandro Di Federico, Stefania Angelicola, Mariateresa Frascino, et al.
Scientific Reports|August 23, 2019
Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigationsPatrizia Nanni, Lorena Landuzzi, Maria Cristina Manara, et al.
JCO Precision Oncology|January 29, 2026
Erratum: Clinical and Preclinical Activity of EGFR Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Harboring BRAF Class 3 MutationsAlessandro Di Federico, Stefania Angelicola, Mariateresa Frascino, et al.
Psychiatry Research|February 3, 2023
Socio-demographic and clinical characteristics of SARS-CoV-2-positive psychiatric in-patients: A case-control study in the psychiatric wards of a Great Metropolitan Hospital in MilanMauro Percudani, Adelaide Panariello, Giacomo Deste, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 7, 2025
Genomic profiling of a collection of patient-derived xenografts and cell lines identified ixabepilone as an active drug against chemo-resistant osteosarcomaMaria Cristina Manara, Francesca Bruzzese, Laura Formentini, et al.
Scientific Reports|January 16, 2021
Early stability and late random tumor progression of a HER2-positive primary breast cancer patient-derived xenograftLorena Landuzzi, Arianna Palladini, Claudio Ceccarelli, et al.
Harvard Review of Psychiatry|May 12, 2021
Universal and Selective Interventions to Prevent Poor Mental Health Outcomes in Young People: Systematic Review and Meta-analysisGonzalo Salazar de Pablo, Andrea De Micheli, Marco Solmi, et al.
Journal of Translational Medicine|January 3, 2025
PD-L1 and IFN-γ modulate Non-Small Cell Lung Cancer (NSCLC) cell plasticity associated to immune checkpoint inhibitor (ICI)-mediated hyperprogressive disease (HPD)Stefania Angelicola, Francesca Giunchi, Francesca Ruzzi, et al.
Pageof 4